Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk H Busch

Showing results (201-210 of 312) with videos related to

Pageof 32
Sort By:
Cells|July 3, 2020
MHC Class I-Restricted TCR-Transgenic CD4<sup>+</sup> T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In VivoSebastian J Schober, Melanie Thiede, Hendrik Gassmann, et al.
Biology|July 29, 2025
The V5-Epitope Tag for Cell Engineering and Its Use in Immunohistochemistry and Quantitative Flow CytometryKatja Fritschle, Marion Mielke, Olga J Seelbach, et al.
Blood|July 14, 2007
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignanciesIngrid G Schuster, Dirk H Busch, Elfriede Eppinger, et al.
Plos One|May 1, 2012
Novel serial positive enrichment technology enables clinical multiparameter cell sortingChristian Stemberger, Stefan Dreher, Claudia Tschulik, et al.
Cell Reports. Medicine|July 19, 2023
Multimodal immune cell phenotyping in GI biopsies reveals microbiome-related T cell modulations in human GvHDSebastian Jarosch, Jan Köhlen, Sakhila Ghimire, et al.
Blood Cancer Journal|June 5, 2021
Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteinsFranziska Blaeschke, Dana Stenger, Antonia Apfelbeck, et al.
Frontiers in Immunology|July 19, 2019
Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat CancerStefan Audehm, Manuel Glaser, Matteo Pecoraro, et al.
Cell Reports. Medicine|December 5, 2024
Modulation of TCR stimulation and pifithrin-α improve the genomic safety profile of CRISPR-engineered human T cellsLaurenz T Ursch, Jule S Müschen, Julia Ritter, et al.
Oncotarget|June 10, 2016
Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivoFranziska Blaeschke, Uwe Thiel, Andreas Kirschner, et al.
Journal of Crohn'S & Colitis|July 15, 2025
Susceptibility to inflammatory bowel diseases promotes invasive carcinomas in a murine model of ATF6-driven colon cancerJanine Kövilein, Adam Sorbie, Sevana Khaloian, et al.
Pageof 32

Showing results (201-210 of 312) with videos related to

Sort By:
Pageof 32
Cells|July 3, 2020
MHC Class I-Restricted TCR-Transgenic CD4<sup>+</sup> T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In VivoSebastian J Schober, Melanie Thiede, Hendrik Gassmann, et al.
Biology|July 29, 2025
The V5-Epitope Tag for Cell Engineering and Its Use in Immunohistochemistry and Quantitative Flow CytometryKatja Fritschle, Marion Mielke, Olga J Seelbach, et al.
Blood|July 14, 2007
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignanciesIngrid G Schuster, Dirk H Busch, Elfriede Eppinger, et al.
Plos One|May 1, 2012
Novel serial positive enrichment technology enables clinical multiparameter cell sortingChristian Stemberger, Stefan Dreher, Claudia Tschulik, et al.
Cell Reports. Medicine|July 19, 2023
Multimodal immune cell phenotyping in GI biopsies reveals microbiome-related T cell modulations in human GvHDSebastian Jarosch, Jan Köhlen, Sakhila Ghimire, et al.
Blood Cancer Journal|June 5, 2021
Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteinsFranziska Blaeschke, Dana Stenger, Antonia Apfelbeck, et al.
Frontiers in Immunology|July 19, 2019
Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat CancerStefan Audehm, Manuel Glaser, Matteo Pecoraro, et al.
Cell Reports. Medicine|December 5, 2024
Modulation of TCR stimulation and pifithrin-α improve the genomic safety profile of CRISPR-engineered human T cellsLaurenz T Ursch, Jule S Müschen, Julia Ritter, et al.
Oncotarget|June 10, 2016
Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivoFranziska Blaeschke, Uwe Thiel, Andreas Kirschner, et al.
Journal of Crohn'S & Colitis|July 15, 2025
Susceptibility to inflammatory bowel diseases promotes invasive carcinomas in a murine model of ATF6-driven colon cancerJanine Kövilein, Adam Sorbie, Sevana Khaloian, et al.
Pageof 32